Nurix Therapeutics, Inc 10-Q for FY2021 Q3
Nurix Therapeutics, Inc. (NRIX)
10-Q
2021-10-14
For: 2021-08-31
View Original
Added on
April 11, 2026
About this 10-Q
Nurix Therapeutics, Inc filed this 10-Q on October 14, 2021, covering the quarter ended August 31, 2021 (FY2021 Q3).
Headline figures
Quarter ended August 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10.25M
- up 151.0% from $4.09M a year earlier
- Net loss
- $28.84M
- compared with a net loss of $18.52M a year earlier